Cargando…
Establishment of MAGEC2‐knockout cells and functional investigation of MAGEC2 in tumor cells
Cancer/testis antigen MAGEC2, a member of the type I melanoma‐associated antigen family, is expressed in a wide variety of cancer types but not in normal somatic cells. MAGEC2 has long been recognized as a tumor‐specific target, however, its functions remain largely unknown. In this study, we establ...
Autores principales: | Wang, Jingjing, Song, Xiao, Guo, Chengli, Wang, Ying, Yin, Yanhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198962/ https://www.ncbi.nlm.nih.gov/pubmed/27636589 http://dx.doi.org/10.1111/cas.13082 |
Ejemplares similares
-
Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cells
por: Song, Xiao, et al.
Publicado: (2018) -
MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis
por: Yang, Fan, et al.
Publicado: (2014) -
Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers
por: Ellegate, James, et al.
Publicado: (2022) -
The Performance of MAGEC X Spine Rods: A Comparative Retrieval Study
por: Tognini, Martina, et al.
Publicado: (2022) -
Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers
por: Omole, Emmanuel B., et al.
Publicado: (2022)